Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Phase II Study of Cabozantinib in Patients With Bone Metastasis

The Oncologist(2022)10.1093/oncolo/oyac083Source: DataRank Database

Phase II Study of Cabozantinib in Patients With Bone Metastasis is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.74)OA: goldTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Gregory A. Coté ORCID,M. Dror Michaelson ORCID,Lori J. Wirth ORCID,Justin F. Gainor ORCID,Alona Muzikansky ORCID

Live enrichment

PubMed:35524758 PMC:PMC9256024 OpenAlex:https://openalex.org/W4225571962

Cancer Center Support

Grant: # NIH 5 P30 CA06516

NCI NIH HHS

Grant: P30 CA006516

National Institutes of Health

Grant: 3P30CA006516-41S6

CANCER CENTER SUPPORT GRANT

NIH

Dana-Farber

NCI

Harvard Cancer Center

FWCI

0.74

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://academic.oup.com/oncolo/article-pdf/27/7/600/44418462/oyac083.pdf

publisherhttps://academic.oup.com/oncolo/article-pdf/27/7/600/44418462/oyac083.pdf

journalhttps://doi.org/10.1093/oncolo/oyac083

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35524758

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9256024

Fields of Study

Cancer Diagnosis and TreatmentSarcoma Diagnosis and TreatmentBone health and treatments03 medical and health sciences0302 clinical medicine

MeSH Terms

AnilidesBone NeoplasmsHumansNeoplasm MetastasisPyridinesSarcoma

Keywords

MedicineCabozantinibResponse Evaluation Criteria in Solid TumorsN-terminal telopeptideBone metastasisBone SarcomaSarcomaInternal medicineBone remodelingMetastasisOncologyClinical trialPhases of clinical researchCancerPathologySkeletal-related EventsMet And Vegf InhibitionPyridinesSarcomasHumansAnilidesBone NeoplasmsNeoplasm Metastasis

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being